2022 NICE 技术鉴定指南:奥拉帕尼用于先前治疗过的 BRCA 突变阳性激素复发转移性 [TA831]前列腺癌

2022-10-05 英国国家卫生与临床优化研究所 NICE官网

奥拉帕尼 (Lynparza) 用于治疗成人 BRCA 突变阳性激素复发转移性前列腺癌的循证建议。

中文标题:

2022 NICE 技术鉴定指南:奥拉帕尼用于先前治疗过的 BRCA 突变阳性激素复发转移性 [TA831]前列腺癌

英文标题:

Olaparib for previously treated BRCA mutationpositive hormone-relapsed metastatic prostate cancer Technology appraisal guidance [TA831]

发布日期:

2022-10-05

简要介绍:

奥拉帕尼 (Lynparza) 用于治疗成人 BRCA 突变阳性激素复发转移性前列腺癌的循证建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=olaparib-for-previously-treated-brca-mutationpositive-hormonerelapsed-metastatic-prostate-cancer-pdf-82613426248645.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e45b61c002e0810d, title=2022 NICE 技术鉴定指南:奥拉帕尼用于先前治疗过的 BRCA 突变阳性激素复发转移性 [TA831]前列腺癌, enTitle=Olaparib for previously treated BRCA mutationpositive hormone-relapsed metastatic prostate cancer Technology appraisal guidance [TA831], guiderFrom=NICE官网, authorId=0, author=, summary=奥拉帕尼 (Lynparza) 用于治疗成人 BRCA 突变阳性激素复发转移性前列腺癌的循证建议。, cover=https://img.medsci.cn/202201006/1665031913369_5579292.png, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Wed Oct 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>奥拉帕尼 (Lynparza) 用于治疗成人 BRCA 突变阳性激素复发转移性前列腺癌的循证建议。</p>, tagList=[TagDto(tagId=781, tagName=前列腺癌), TagDto(tagId=12414, tagName=奥拉帕尼), TagDto(tagId=12415, tagName=BRCA)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1749, appHits=59, showAppHits=0, pcHits=175, showPcHits=1690, likes=0, shares=16, comments=0, approvalStatus=1, publishedTime=Wed Oct 12 20:50:00 CST 2022, publishedTimeString=2022-10-05, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Oct 06 12:53:18 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 18:20:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=olaparib-for-previously-treated-brca-mutationpositive-hormonerelapsed-metastatic-prostate-cancer-pdf-82613426248645.pdf)])
olaparib-for-previously-treated-brca-mutationpositive-hormonerelapsed-metastatic-prostate-cancer-pdf-82613426248645.pdf
下载请点击:
评论区 (0)
#插入话题